Caroline D. Dorsa
Caroline D. Dorsa founded Institute For Advanced Clinical Trials For Children. Ms. Dorsa is on the board of Biogen, Inc. and 9 other companies.
In her past career she was Chief Financial Officer & Senior Vice President for Gilead Sciences, Inc., Chief Financial Officer & Executive Vice President at Public Service Enterprise Group, Inc. Chief Financial Officer & Executive Vice President of Public Service Electric & Gas Co. Chief Financial Officer of PSEG Energy Holdings LLC, Chief Financial Officer, Director & Executive VP at PSEG Power LLC and Chief Financial Officer & Executive Vice President for PSEG Services Corp. (which are all subsidiaries of Public Service Enterprise Group, Inc.), SVP-Global Human, Health, Strategy & Integration at Merck & Co., Inc. and Chief Financial Officer & Senior Vice President for Avaya, Inc.
She received an undergraduate degree from Colgate University and an MBA from Columbia Business School.
Transactions
| 05/26/2022 | 1,232 | Award at $0 per share. | 0 |
| 05/25/2022 | 352 | Derivative/Non-derivative trans. at $242.4 per share. | 85,325 |
| 06/10/2021 | 1,000 | Disposition at $450 per share. | 450,000 |
| 05/26/2021 | 881 | Award at $0 per share. | 0 |
| 05/25/2021 | 385 | Derivative/Non-derivative trans. at $397.09 per share. | 152,880 |
| 05/27/2020 | 963 | Award at $0 per share. | 0 |
| 05/26/2020 | 519 | Derivative/Non-derivative trans. at $354.41 per share. | 183,939 |
| 05/29/2019 | 1,298 | Award at $0 per share. | 0 |
| 05/23/2019 | 589 | Derivative/Non-derivative trans. at $308.97 per share. | 181,984 |
| 05/23/2018 | 1,473 | Award at $0 per share. | 0 |
| 05/22/2018 | 922 | Derivative/Non-derivative trans. at $270.8 per share. | 249,678 |
